Literature DB >> 2555420

Congenital cytomegalovirus labyrinthitis and sensorineural hearing loss in guinea pigs.

N K Woolf1, F J Koehrn, J P Harris, D D Richman.   

Abstract

Cytomegalovirus (CMV) is the leading cause of human nonhereditary congenital deafness. The pathogenesis of congenital CMV infection in the auditory system is poorly understood and no suitable animal model is currently recognized. In this study primary maternal CMV infection in guinea pigs during the first or second trimester of pregnancy resulted in congenital infection in 64% of the offspring. Of the congenitally infected neonates, 28% had significant auditory deficits. Within the inner ear, CMV infection was localized in auditory nerve spiral ganglion cells. These findings indicate that congenital CMV infection of the guinea pig results in physiologic and anatomic neuropathology similar to that seen in human infection and provide the first experimental model for congenital CMV-induced sensorineural hearing loss.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555420     DOI: 10.1093/infdis/160.6.929

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  A trimeric capable gB CMV vaccine provides limited protection against a highly cell associated and epithelial tropic strain of cytomegalovirus in guinea pigs.

Authors:  K Yeon Choi; Nadia S El-Hamdi; Alistair McGregor
Journal:  J Gen Virol       Date:  2021-03-17       Impact factor: 3.891

Review 2.  Cytomegalovirus antivirals and development of improved animal models.

Authors:  Alistair McGregor; K Yeon Choi
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-09-01       Impact factor: 4.481

3.  Neutralizing antibodies to gB based CMV vaccine requires full length antigen but reduced virus neutralization on non-fibroblast cells limits vaccine efficacy in the guinea pig model.

Authors:  K Yeon Choi; Nadia S El-Hamdi; Alistair McGregor
Journal:  Vaccine       Date:  2020-01-31       Impact factor: 3.641

Review 4.  Animal Models of Congenital Cytomegalovirus Transmission: Implications for Vaccine Development.

Authors:  Hunter K Roark; Jennifer A Jenks; Sallie R Permar; Mark R Schleiss
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

Review 5.  Models of vertical cytomegalovirus (CMV) transmission and pathogenesis.

Authors:  Yiska Weisblum; Amos Panet; Ronit Haimov-Kochman; Dana G Wolf
Journal:  Semin Immunopathol       Date:  2014-10-08       Impact factor: 9.623

6.  Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next?

Authors:  Mark R Schleiss
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

7.  Cytomegalovirus shedding and delayed sensorineural hearing loss: results from longitudinal follow-up of children with congenital infection.

Authors:  Lauren Stancik Rosenthal; Karen B Fowler; Suresh B Boppana; William J Britt; Robert F Pass; Scott D Schmid; Sergio Stagno; Michael J Cannon
Journal:  Pediatr Infect Dis J       Date:  2009-06       Impact factor: 2.129

8.  Cytomegalovirus blood viral load and hearing loss in young children with congenital infection.

Authors:  Shannon A Ross; Zdenek Novak; Karen B Fowler; Nitin Arora; William J Britt; Suresh B Boppana
Journal:  Pediatr Infect Dis J       Date:  2009-07       Impact factor: 2.129

9.  Association of Adverse Hearing, Growth, and Discharge Age Outcomes With Postnatal Cytomegalovirus Infection in Infants With Very Low Birth Weight.

Authors:  Kristin E D Weimer; Matthew S Kelly; Sallie R Permar; Reese H Clark; Rachel G Greenberg
Journal:  JAMA Pediatr       Date:  2020-02-01       Impact factor: 16.193

10.  Guinea Pig Cytomegalovirus (GPCMV): A Model for the Study of the Prevention and Treatment of Maternal-Fetal Transmission.

Authors:  Mark R Schleiss; Michael A McVoy
Journal:  Future Virol       Date:  2010-03       Impact factor: 1.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.